Sublingual film containing Dexmedetomidine + Sublingual Placebo Film
Phase 1/2Completed 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Agitation,Psychomotor
Conditions
Agitation,Psychomotor, Dementia
Trial Timeline
Dec 27, 2019 → Jan 24, 2022
NCT ID
NCT04251910About Sublingual film containing Dexmedetomidine + Sublingual Placebo Film
Sublingual film containing Dexmedetomidine + Sublingual Placebo Film is a phase 1/2 stage product being developed by BioXcel Therapeutics for Agitation,Psychomotor. The current trial status is completed. This product is registered under clinical trial identifier NCT04251910. Target conditions include Agitation,Psychomotor, Dementia.
What happened to similar drugs?
2 of 14 similar drugs in Agitation,Psychomotor were approved
Approved (2) Terminated (2) Active (10)
Hype Score Breakdown
Clinical
9
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04251910 | Phase 1/2 | Completed |
Competing Products
20 competing products in Agitation,Psychomotor